Health Helen Branswell WHO raises possibility of ‘sustained’ human-to-human transmission of new virus in China
Biotech Damian Garde and Lev Facher STAT Plus: Former Rep. Chris Collins sentenced to 26 months in prison in biotech insider trading scheme
Biotech Matthew Herper STAT Plus: FDA approves Amarin fish-oil-derived drug to prevent heart attacks and strokes
Biotech Damian Garde STAT Plus: FDA changes course on Sarepta’s once-rejected muscular dystrophy drug
Biotech Adam Feuerstein and Damian Garde STAT Plus: New data show Bluebird, Bristol CAR-T drug could be pioneering myeloma therapy. Competitors may be close behind
Biotech Matthew Herper and Adam Feuerstein STAT Plus: Sage’s new antidepressant faces major setback in new study
Health Helen Branswell Four Ebola-response workers killed in attacks, forcing withdrawal from critical DRC region
Health Tech Megan Thielking and Rebecca Robbins STAT Plus: Google to acquire Fitbit for $2.1 billion in major health tech deal
Biotech Adam Feuerstein STAT Plus: Novartis’ Zolgensma gene therapy study halted by FDA on animal safety concerns
Pharma Andrew Joseph and Casey Ross STAT Plus: STAT wins long legal fight as Kentucky Supreme Court clears way for release of Purdue OxyContin files
Biotech Matthew Herper STAT Plus: Top scientist categorically denies any wrongdoing in Novartis data manipulation scandal
Health Helen Branswell For the first time, clinical trial results show Ebola drugs improve survival rates
Business Adam Feuerstein and Matthew Herper STAT Plus: AbbVie to acquire Allergan for $63 billion in megamerger of pharma giants
Health Sharon Begley Fertility clinics around the world asked ‘CRISPR babies’ scientist for how-to help
Health Helen Branswell Measles case count in the U.S. tops 700 this year, as health officials urge vaccinations
In the Lab Sharon Begley The pigs were dead. But four hours later, scientists restored cellular functions in their brains
Health Sharon Begley Zapping brain with precise electrical current boosts working memory in older adults, study finds
Biotech Matthew Herper STAT Plus: Regeneron to invest $800 million in Alnylam, betting on drug-making technique enabled by a Nobel-winning discovery
Biotech Damian Garde STAT Plus: Bristol-Myers scores critical endorsements for its embattled Celgene merger
Health Helen Branswell New York county, declaring emergency over measles, seeks to ban unvaccinated from public places
Biotech Adam Feuerstein STAT Plus: A Regeneron drug dominates eczema treatment. With new data, a small biotech believes it can compete
Biotech Adam Feuerstein STAT Plus: First attempt at genome editing in U.S. patients produces disappointing — and sobering — results